BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27853939)

  • 1. Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.
    Lo Iacono M; Anzalone R; La Rocca G; Baiamonte E; Maggio A; Acuto S
    Stem Cell Rev Rep; 2017 Feb; 13(1):35-49. PubMed ID: 27853939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells.
    Gounari E; Daniilidis A; Tsagias N; Michopoulou A; Kouzi K; Koliakos G
    Cytotherapy; 2019 Feb; 21(2):246-259. PubMed ID: 30522805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.
    Batsali AK; Kastrinaki MC; Papadaki HA; Pontikoglou C
    Curr Stem Cell Res Ther; 2013 Mar; 8(2):144-55. PubMed ID: 23279098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood.
    Bonilla X; Lara AM; Llano-León M; López-González DA; Hernández-Mejía DG; Bustos RH; Camacho-Rodríguez B; Perdomo-Arciniegas AM
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.
    Bakhshi T; Zabriskie RC; Bodie S; Kidd S; Ramin S; Paganessi LA; Gregory SA; Fung HC; Christopherson KW
    Transfusion; 2008 Dec; 48(12):2638-44. PubMed ID: 18798803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.
    Fong CY; Gauthaman K; Cheyyatraivendran S; Lin HD; Biswas A; Bongso A
    J Cell Biochem; 2012 Feb; 113(2):658-68. PubMed ID: 21976004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow.
    Klein C; Strobel J; Zingsem J; Richter RH; Goecke TW; Beckmann MW; Eckstein R; Weisbach V
    Tissue Eng Part A; 2013 Dec; 19(23-24):2577-85. PubMed ID: 24308543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.
    De Bruyn C; Najar M; Raicevic G; Meuleman N; Pieters K; Stamatopoulos B; Delforge A; Bron D; Lagneaux L
    Stem Cells Dev; 2011 Mar; 20(3):547-57. PubMed ID: 20923277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.